How cancer cells loose their (Circadian) rhythm

	Tweet

Immortality and uncontrolled cell division are the fundamental differences between cancer cells and normal cells.

A widely held explanation for these differences is that the biological clocks in cancer cells are damaged and can’t regulate cell division in the fashion that they do in normal cells.

This assumption is challenged by the results of the first experiment that has continuously monitored variations in the rate of cell division of cultured mammalian cells for extended periods. The results are reported this week in a paper published in the online Early Edition of the Proceedings of the National Academy of Sciences.

The experiment discovered that one line of immortal cells have functioning biological clocks but their internal clocks have no effect on the rate at which they divide and grow. (Immortal cells have the same basic properties as cancer cells but are created in the laboratory where they are used for a wide variety of purposes.)

“The current assumption has been that the biological clocks in cancer cells have been disabled,” says Julie Pendergast, a research associate who participated in the study. “We determined that the immortalized cells in our experiment had functioning biological clocks but these clocks don’t control the process of cell division. That is the paradigm shifting aspect of our study.”

If confirmed by follow-up studies, this insight could aid in the development of new cancer therapies.

“This strengthens the possibility that the biological clock pathway could be an effective target for anti-cancer drugs,” says Shin Yamazaki, the research professor of biological sciences at Vanderbilt who directed the project. “For example, if a drug could be found that restores the control of the biological clock over cancer cell division, it could reduce tumor growth.”

Biologists have observed that cell division in normal cells in species ranging from unicellular organisms to humans peaks at specific times of the day and consider this as indirect evidence that the process is regulated by their internal biological clocks. Cells in the human mouth, for example, tend to divide in the evening, just before nightfall.

“There is a general evolutionary explanation for this,” says research associate Julie Pendergast who participated in the study. “Ultraviolet light is one of the primary causes of mutations. Cells are particularly vulnerable to mutations during cell division. So organisms with cells that divide at night have a selective advantage.”

In addition, there has been a considerable amount of indirect evidence that mitosis (division) in cancer cells is not under 24-hour control. For example, “experiments have found that cells turn cancerous when certain circadian clock genes have been knocked out,” says Yamazaki. The results of other experiments that have periodically sampled cancer cell division rates also support this possibility.

Yamazaki designed and built a special system to monitor cell division in real time. He and his colleagues designed a special “reporter” molecule incorporating a gene that produces an enzyme that makes green light. They figured out how to insert this reporter into a cell’s genome so that it produces the luminescent enzyme when the cell divides. This allows them to use a camera to continuously measure variations in the rate of cell division over long periods of time.

For the current experiment, the researchers inserted their special reporter into immortalized rat fibroblasts formed from connective tissue taken from rats. They selected this cell line because it was known to have working circadian clocks.

They have obtained consistent results in preliminary studies of lung cancer cells.

###

The other participants in the study were Professor Yoshihiro Ohmiya at the Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan and post-doctoral researcher Mijung Yeom, now at the Acupuncture and Meridian Science Research Center, Kyung Hee University in Seoul, South Korea.

The research was supported by funds from the National Institutes of Health, Research Foundation for Opto-Science and Technology, the NEDO Project and Takeda Science Foundation.

For more news about Vanderbilt, visit the Vanderbilt News Service homepage on the Internet at http://www.vanderbilt.edu/News.

---
Contact: David F. Salisbury

615-343-6803
Vanderbilt University

RELATED STORIES:
Mayo Clinic Researchers Find That Protein Believed to Protect Against Cancer Has a Mr. Hyde Side   Cell Path Overdrive Prevents Cancer Response to Diet Restriction   Parents of kids with cancer face traumatic stress   Researchers Develop and Improve Techniques for Treating Cancer   Late-Breaking Science and Clinical Trials   Scientists devise targeted therapy strategy for rare form of childhood cancer   Online Information May Improve Cancer Patients’ Opinions About Doctors   Body Weight, Diet May Be Risk Factors for Non-Hodgkin Lymphoma   Dying at home better for cancer patients   Van Andel Research Institute Finding Could Lead to Reduced Side Effects in Anti-Cancer Antibiotics   Arsenic implicated in etiology of cancer   UK cancer survival rates, spending lag Europe   Cancer costs highest for individually insured   Study reveals cancer-linked epigenetic effects of smoking   Scientists develop new approach for cancer vaccine   Scientists announce new advance with potential for future cancer targeting   Childhood cancer mortality high in UK in children   Obesity-Related Cancer on the Rise   Green tea extract may boost cancer-fighting enzymes   New study widens cancer risks and benefits of pill   Study suggests a way to eliminate glioblastoma   Active lifestyle may prevent cancer: Japan study

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]